| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Angiotensin-converting enzyme 2 is an essential regulator of heart function.
|
Nature
|
2002
|
5.02
|
|
2
|
Value of noninvasive hemodynamics to achieve blood pressure control in hypertensive subjects.
|
Hypertension
|
2006
|
2.31
|
|
3
|
Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats.
|
Am J Hypertens
|
2013
|
2.11
|
|
4
|
Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors.
|
Hypertension
|
2004
|
1.96
|
|
5
|
Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats.
|
Am J Physiol Heart Circ Physiol
|
2005
|
1.92
|
|
6
|
Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats.
|
Exp Physiol
|
2005
|
1.85
|
|
7
|
ACE2 and ANG-(1-7) in the rat uterus during early and late gestation.
|
Am J Physiol Regul Integr Comp Physiol
|
2007
|
1.85
|
|
8
|
Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor.
|
Am J Physiol Heart Circ Physiol
|
2005
|
1.81
|
|
9
|
Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II.
|
Am J Physiol Renal Physiol
|
2006
|
1.61
|
|
10
|
Diabetes, hypertension, and dyslipidemia in Mexican Americans and non-Hispanic whites.
|
Am J Prev Med
|
2006
|
1.56
|
|
11
|
Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension.
|
Hypertension
|
2009
|
1.52
|
|
12
|
Differential expression of nuclear AT1 receptors and angiotensin II within the kidney of the male congenic mRen2. Lewis rat.
|
Am J Physiol Renal Physiol
|
2006
|
1.48
|
|
13
|
Impaired heart rate baroreflex in older rats: role of endogenous angiotensin-(1-7) at the nucleus tractus solitarii.
|
Hypertension
|
2005
|
1.45
|
|
14
|
Sex differences in circulating and renal angiotensins of hypertensive mRen(2). Lewis but not normotensive Lewis rats.
|
Am J Physiol Heart Circ Physiol
|
2008
|
1.41
|
|
15
|
Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes.
|
Am J Physiol Cell Physiol
|
2005
|
1.40
|
|
16
|
Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase.
|
Am J Physiol Endocrinol Metab
|
2007
|
1.36
|
|
17
|
Angiotensin-(1-12) is an alternate substrate for angiotensin peptide production in the heart.
|
Am J Physiol Heart Circ Physiol
|
2008
|
1.34
|
|
18
|
Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression.
|
Am J Physiol Endocrinol Metab
|
2004
|
1.33
|
|
19
|
NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat.
|
Hypertension
|
2007
|
1.32
|
|
20
|
Estrogen or the AT1 antagonist olmesartan reverses the development of profound hypertension in the congenic mRen2. Lewis rat.
|
Hypertension
|
2003
|
1.32
|
|
21
|
Angiotensin-(1-7) in normal and preeclamptic pregnancy.
|
Endocrine
|
2002
|
1.30
|
|
22
|
Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2.
|
Cancer Res
|
2007
|
1.28
|
|
23
|
Injections of angiotensin-converting enzyme 2 inhibitor MLN4760 into nucleus tractus solitarii reduce baroreceptor reflex sensitivity for heart rate control in rats.
|
Exp Physiol
|
2008
|
1.24
|
|
24
|
Renin inhibition attenuates insulin resistance, oxidative stress, and pancreatic remodeling in the transgenic Ren2 rat.
|
Endocrinology
|
2008
|
1.21
|
|
25
|
Localization of the novel angiotensin peptide, angiotensin-(1-12), in heart and kidney of hypertensive and normotensive rats.
|
Am J Physiol Heart Circ Physiol
|
2008
|
1.20
|
|
26
|
MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides.
|
Am J Physiol Cell Physiol
|
2008
|
1.20
|
|
27
|
Regulation of ACE2 in cardiac myocytes and fibroblasts.
|
Am J Physiol Heart Circ Physiol
|
2008
|
1.20
|
|
28
|
Angiotensin-(1-7) and baroreflex function in nucleus tractus solitarii of (mRen2)27 transgenic rats.
|
J Cardiovasc Pharmacol
|
2008
|
1.20
|
|
29
|
Chymase-dependent generation of angiotensin II from angiotensin-(1-12) in human atrial tissue.
|
PLoS One
|
2011
|
1.17
|
|
30
|
Effect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat.
|
Am J Physiol Endocrinol Metab
|
2008
|
1.15
|
|
31
|
Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells.
|
Br J Haematol
|
2004
|
1.15
|
|
32
|
Modulation of reflex function by endogenous angiotensins in older transgenic rats with low glial angiotensinogen.
|
Hypertension
|
2008
|
1.12
|
|
33
|
Activation of local chorionic villi angiotensin II levels but not angiotensin (1-7) in preeclampsia.
|
Hypertension
|
2008
|
1.10
|
|
34
|
Cardiac angiotensin-(1-7) in ischemic cardiomyopathy.
|
Circulation
|
2003
|
1.09
|
|
35
|
Angiotensin-(1-7): pharmacology and new perspectives in cardiovascular treatments.
|
Cardiovasc Drug Rev
|
2007
|
1.08
|
|
36
|
Cardiac kallikrein-kinin system is upregulated in chronic volume overload and mediates an inflammatory induced collagen loss.
|
PLoS One
|
2012
|
1.08
|
|
37
|
Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats.
|
J Hepatol
|
2008
|
1.06
|
|
38
|
Growth, metabolism, and blood pressure disturbances during aging in transgenic rats with altered brain renin-angiotensin systems.
|
Physiol Genomics
|
2005
|
1.06
|
|
39
|
Novel aspects of the renal renin-angiotensin system: angiotensin-(1-7), ACE2 and blood pressure regulation.
|
Contrib Nephrol
|
2004
|
1.06
|
|
40
|
Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.
|
Am J Physiol Heart Circ Physiol
|
2006
|
1.05
|
|
41
|
Baroreceptor reflex regulation in anesthetized transgenic rats with low glia-derived angiotensinogen.
|
Am J Physiol Heart Circ Physiol
|
2006
|
1.05
|
|
42
|
Mineralocorticoid receptor antagonism attenuates glomerular filtration barrier remodeling in the transgenic Ren2 rat.
|
Am J Physiol Renal Physiol
|
2009
|
1.04
|
|
43
|
Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin-(1-7) in transgenic Ren-2 hypertensive rats.
|
Am J Physiol Heart Circ Physiol
|
2007
|
1.04
|
|
44
|
Allelic variants of the human scavenger receptor class B type 1 and paraoxonase 1 on coronary heart disease: genotype-phenotype correlations.
|
Arterioscler Thromb Vasc Biol
|
2005
|
1.04
|
|
45
|
Angiotensin-(1-12) requires angiotensin converting enzyme and AT1 receptors for cardiovascular actions within the solitary tract nucleus.
|
Am J Physiol Heart Circ Physiol
|
2010
|
1.03
|
|
46
|
Angiotensin II activation of mTOR results in tubulointerstitial fibrosis through loss of N-cadherin.
|
Am J Nephrol
|
2011
|
1.03
|
|
47
|
Nebivolol reduces proteinuria and renal NADPH oxidase-generated reactive oxygen species in the transgenic Ren2 rat.
|
Am J Nephrol
|
2009
|
1.02
|
|
48
|
Enhanced renal immunocytochemical expression of ANG-(1-7) and ACE2 during pregnancy.
|
Hypertension
|
2003
|
1.01
|
|
49
|
Chronic immunoneutralization of brain angiotensin-(1-12) lowers blood pressure in transgenic (mRen2)27 hypertensive rats.
|
Am J Physiol Regul Integr Comp Physiol
|
2009
|
1.01
|
|
50
|
New angiotensins.
|
J Mol Med (Berl)
|
2008
|
1.00
|
|
51
|
Aging and the brain renin-angiotensin system: insights from studies in transgenic rats.
|
Cleve Clin J Med
|
2007
|
1.00
|
|
52
|
Uptake and metabolism of the novel peptide angiotensin-(1-12) by neonatal cardiac myocytes.
|
PLoS One
|
2011
|
1.00
|
|
53
|
Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart.
|
Exp Physiol
|
2008
|
1.00
|
|
54
|
Mineralocorticoid receptor antagonism attenuates vascular apoptosis and injury via rescuing protein kinase B activation.
|
Hypertension
|
2008
|
0.99
|
|
55
|
Rats with low brain angiotensinogen do not exhibit insulin resistance during early aging.
|
Endocrine
|
2006
|
0.97
|
|
56
|
Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome.
|
Am J Med Sci
|
2005
|
0.96
|
|
57
|
Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats.
|
Am J Hypertens
|
2010
|
0.95
|
|
58
|
Sex differences in baroreflex sensitivity, heart rate variability, and end organ damage in the TGR(mRen2)27 rat.
|
Am J Physiol Heart Circ Physiol
|
2011
|
0.95
|
|
59
|
Characterization of the cardiac renin angiotensin system in oophorectomized and estrogen-replete mRen2.Lewis rats.
|
PLoS One
|
2013
|
0.95
|
|
60
|
Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States.
|
Am J Med Sci
|
2005
|
0.94
|
|
61
|
Angiotensin receptors contribute to blood pressure homeostasis in salt-depleted SHR.
|
Am J Physiol Regul Integr Comp Physiol
|
2003
|
0.94
|
|
62
|
Beneficial versus harmful effects of Angiotensin (1-7) on impulse propagation and cardiac arrhythmias in the failing heart.
|
J Renin Angiotensin Aldosterone Syst
|
2007
|
0.93
|
|
63
|
Angiotensin I, angiotensin II and their biologically active peptides.
|
J Hypertens
|
2002
|
0.93
|
|
64
|
Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy.
|
Vasc Health Risk Manag
|
2007
|
0.93
|
|
65
|
Mechanisms linking angiotensin II and atherogenesis.
|
Curr Opin Lipidol
|
2002
|
0.92
|
|
66
|
ACE2: angiotensin II/angiotensin-(1-7) balance in cardiac and renal injury.
|
Curr Hypertens Rep
|
2014
|
0.92
|
|
67
|
Does angiotensin-(1-7) contribute to cardiac adaptation and preservation of endothelial function in heart failure?
|
Circulation
|
2002
|
0.91
|
|
68
|
Chymase mediates angiotensin-(1-12) metabolism in normal human hearts.
|
J Am Soc Hypertens
|
2013
|
0.90
|
|
69
|
Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.
|
Am J Physiol Renal Physiol
|
2009
|
0.89
|
|
70
|
Salt-induced renal injury in spontaneously hypertensive rats: effects of nebivolol.
|
Am J Nephrol
|
2010
|
0.89
|
|
71
|
Rosuvastatin ameliorates the development of pulmonary arterial hypertension in the transgenic (mRen2)27 rat.
|
Am J Physiol Heart Circ Physiol
|
2009
|
0.88
|
|
72
|
Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the transgenic (mRen2) rat.
|
Am J Physiol Heart Circ Physiol
|
2012
|
0.87
|
|
73
|
Combination of direct renin inhibition with angiotensin type 1 receptor blockade improves aldosterone but does not improve kidney injury in the transgenic Ren2 rat.
|
Regul Pept
|
2012
|
0.87
|
|
74
|
Pregnancy enhances the angiotensin (Ang)-(1-7) vasodilator response in mesenteric arteries and increases the renal concentration and urinary excretion of Ang-(1-7).
|
Endocrinology
|
2003
|
0.87
|
|
75
|
The protective effects of angiotensin II blockade with olmesartan medoxomil on resistance vessel remodeling (The VIOS study): rationale and baseline characteristics.
|
Am J Cardiovasc Drugs
|
2006
|
0.87
|
|
76
|
Blood pressure-independent attenuation of cardiac hypertrophy by AT(1)R-AS gene therapy.
|
Hypertension
|
2002
|
0.87
|
|
77
|
Concern
Oxidative stress-mediated mitochondrial dysfunction contributes to angiotensin II-induced nonalcoholic fatty liver disease in transgenic Ren2 rats.
|
Am J Pathol
|
2009
|
0.86
|
|
78
|
Hemodynamic and hormonal changes to dual renin-angiotensin system inhibition in experimental hypertension.
|
Hypertension
|
2012
|
0.86
|
|
79
|
Olmesartan for the treatment of arterial hypertension.
|
Future Cardiol
|
2008
|
0.85
|
|
80
|
Nebivolol reduces cardiac angiotensin II, associated oxidative stress and fibrosis but not arterial pressure in salt-loaded spontaneously hypertensive rats.
|
J Hypertens
|
2012
|
0.85
|
|
81
|
Restoration of the blood pressure circadian rhythm by direct renin inhibition and blockade of angiotensin II receptors in mRen2.Lewis hypertensive rats.
|
Ther Adv Cardiovasc Dis
|
2012
|
0.85
|
|
82
|
Divergent regulation of circulating and intrarenal renin-angiotensin systems in response to long-term blockade.
|
Am J Nephrol
|
2005
|
0.84
|
|
83
|
Characterization of angiotensin-(1-7) receptor subtype in mesenteric arteries.
|
Peptides
|
2003
|
0.84
|
|
84
|
Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy.
|
Am J Hypertens
|
2005
|
0.84
|
|
85
|
Angiotensin peptides modulate bradykinin levels in the interstitium of the dog heart in vivo.
|
J Pharmacol Exp Ther
|
2002
|
0.84
|
|
86
|
Reversal of vascular hypertrophy in hypertensive patients through blockade of angiotensin II receptors.
|
J Am Soc Hypertens
|
2010
|
0.83
|
|
87
|
Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade.
|
Hypertens Res
|
2008
|
0.83
|
|
88
|
Decreased cardiac Ang-(1-7) is associated with salt-induced cardiac remodeling and dysfunction.
|
Ther Adv Cardiovasc Dis
|
2009
|
0.83
|
|
89
|
Angiotensin-(1-12): a chymase-mediated cellular angiotensin II substrate.
|
Curr Hypertens Rep
|
2014
|
0.83
|
|
90
|
Nebivolol improves insulin sensitivity in the TGR(Ren2)27 rat.
|
Metabolism
|
2011
|
0.83
|
|
91
|
Central depletion of angiotensinogen is associated with elevated AT1 receptors in the SFO and PVN.
|
Neurotox Res
|
2004
|
0.83
|
|
92
|
Reduced circulating levels of angiotensin-(1--7) in systemic sclerosis: a new pathway in the dysregulation of endothelial-dependent vascular tone control.
|
Ann Rheum Dis
|
2007
|
0.83
|
|
93
|
Noninvasive hemodynamic profiles in hypertensive subjects.
|
Am J Hypertens
|
2005
|
0.82
|
|
94
|
Renin inhibition and AT(1)R blockade improve metabolic signaling, oxidant stress and myocardial tissue remodeling.
|
Metabolism
|
2013
|
0.82
|
|
95
|
Self-reported influences of hopelessness, health literacy, lifestyle action, and patient inertia on blood pressure control in a hypertensive emergency department population.
|
Am J Med Sci
|
2009
|
0.82
|
|
96
|
Estrogen, nitric oxide, and hypertension differentially modulate agonist-induced contractile responses in female transgenic (mRen2)27 hypertensive rats.
|
Am J Physiol Heart Circ Physiol
|
2008
|
0.82
|
|
97
|
Alterations in sympathetic ganglionic transmission in response to angiotensin II in (mRen2)27 transgenic rats.
|
Hypertension
|
2004
|
0.81
|
|
98
|
Comparison of inhibitory effects of irbesartan and atorvastatin treatment on the renin angiotensin system (RAS) in veins: a randomized double-blind crossover trial in healthy subjects.
|
J Clin Pharmacol
|
2007
|
0.81
|
|
99
|
Primacy of angiotensin converting enzyme in angiotensin-(1-12) metabolism.
|
Am J Physiol Heart Circ Physiol
|
2013
|
0.81
|
|
100
|
Vascular responses to Angiotensin-(1-7) during the estrous cycle.
|
Endocrine
|
2004
|
0.81
|
|
101
|
Mineralocorticoid receptor-dependent proximal tubule injury is mediated by a redox-sensitive mTOR/S6K1 pathway.
|
Am J Nephrol
|
2011
|
0.81
|
|
102
|
Angiotensin II stimulates arachidonic acid release from bone marrow stromal cells.
|
J Renin Angiotensin Aldosterone Syst
|
2004
|
0.81
|
|
103
|
The effect of methylenetetrahydrofolate reductase C677T common variant on hypertensive risk is not solely explained by increased plasma homocysteine values.
|
Clin Exp Hypertens
|
2003
|
0.81
|
|
104
|
Angiotensin II AT1 receptor blockade normalizes CD11b+ monocyte production in bone marrow of hypercholesterolemic monkeys.
|
Atherosclerosis
|
2007
|
0.80
|
|
105
|
Cardioprotective role for angiotensin-(1-7) and angiotensin converting enzyme 2 in the heart.
|
Future Cardiol
|
2006
|
0.79
|
|
106
|
Salt loading exacerbates diastolic dysfunction and cardiac remodeling in young female Ren2 rats.
|
Metabolism
|
2013
|
0.79
|
|
107
|
Exercise training prevents development of cardiac contractile dysfunction in hypertensive TG (mREN-2)27 rats.
|
J Am Soc Hypertens
|
2010
|
0.79
|
|
108
|
Mast Cell Inhibition Attenuates Cardiac Remodeling and Diastolic Dysfunction in Middle-aged, Ovariectomized Fischer 344 × Brown Norway Rats.
|
J Cardiovasc Pharmacol
|
2016
|
0.79
|
|
109
|
Noninvasive ultrasound evaluation of the vertebral artery in hypertension.
|
J Neuroimaging
|
2002
|
0.79
|
|
110
|
Low glial angiotensinogen improves body habitus, diastolic function, and exercise tolerance in aging male rats.
|
Cardiovasc Endocrinol
|
2012
|
0.78
|
|
111
|
Hypertension-linked decrease in the expression of brain gamma-adducin.
|
Circ Res
|
2002
|
0.78
|
|
112
|
The impact of changing ICD code on hypertension-related mortality in the southeastern United States from 1994-2005.
|
J Clin Hypertens (Greenwich)
|
2010
|
0.78
|
|
113
|
Myocardial infarction increases ACE2 expression in rat and humans.
|
Eur Heart J
|
2005
|
0.77
|
|
114
|
Commentary on Tikellis et al: There is more to discover about angiotensin-converting enzyme.
|
Hypertension
|
2003
|
0.77
|
|
115
|
Impact of performance improvement continuing medical education on cardiometabolic risk factor control: the COSEHC initiative.
|
J Contin Educ Health Prof
|
2014
|
0.77
|
|
116
|
Attenuation of hypertension-mediated glomerulosclerosis in conjunction with increased angiotensin (1-7).
|
Ther Adv Cardiovasc Dis
|
2011
|
0.76
|
|
117
|
Differential effect of low dose thiazides on the Renin Angiotensin system in genetically hypertensive and normotensive rats.
|
J Am Soc Hypertens
|
2010
|
0.76
|
|
118
|
Of gender, statins, and coronary artery interventions.
|
Ther Adv Cardiovasc Dis
|
2008
|
0.76
|
|
119
|
Increased hypothalamic angiotensin-(1-7) levels in rats with aortic coarctation-induced hypertension.
|
Peptides
|
2007
|
0.76
|
|
120
|
Emergency department patients self-report higher patient inertia, hopelessness, and harmful lifestyle choices than community counterparts.
|
J Clin Hypertens (Greenwich)
|
2012
|
0.76
|
|
121
|
The never-ending story of angiotensin peptides: beyond angiotensin I and II.
|
Circ Res
|
2013
|
0.76
|
|
122
|
Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.
|
J Cardiometab Syndr
|
2006
|
0.75
|
|
123
|
Response to "Angiotensin-(1-7) in the central regulation of blood pressure and renin-angiotensin system".
|
Am J Hypertens
|
2013
|
0.75
|
|
124
|
Therapeutic Advances in Cardiovascular Disease. Editorial.
|
Ther Adv Cardiovasc Dis
|
2015
|
0.75
|
|
125
|
Association between antihypertensive agent use and hospital admissions in a managed care population.
|
Am J Med Sci
|
2004
|
0.75
|
|
126
|
On the selective inhibitors of Cyclooxygenase-2: do we have a last word?
|
Ther Adv Cardiovasc Dis
|
2008
|
0.75
|
|
127
|
Editorial: journal accomplishments in just one short year.
|
Ther Adv Cardiovasc Dis
|
2009
|
0.75
|
|
128
|
Self-reported cardiovascular disease risk factors and associated hopelessness in African American participants of a church-placed health screening program.
|
Ethn Dis
|
2014
|
0.75
|
|
129
|
New approaches to hypertension management: always reasonable but now necessary.
|
Am J Hypertens
|
2005
|
0.75
|
|
130
|
Memorial.
|
Ther Adv Cardiovasc Dis
|
2009
|
0.75
|
|
131
|
Questions to ponder.
|
Ther Adv Cardiovasc Dis
|
2008
|
0.75
|
|
132
|
Left ventricular geometric patterns after 1 year of antihypertensive treatment.
|
J Clin Hypertens (Greenwich)
|
2005
|
0.75
|
|
133
|
Comparative effects of a novel angiotensin-converting enzyme inhibitor versus captopril on plasma angiotensins after myocardial infarction.
|
Pharmacology
|
2014
|
0.75
|